Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abaxis

This article was originally published in The Gray Sheet

Executive Summary

Nets $9.4 mil. in an offering of 2.35 mil. common shares. The Sunnyvale, California-based blood analysis systems manufacturer registered the shares with the Securities and Exchange Commission in August ("The Gray Sheet" Sept. 5, p. 23). The proceeds, according to the company, will help "enable Abaxis to measurably improve its liquidity and focus the necessary resources on" commercializing the VetScan veterinary product and on gaining FDA marketing clearance for the Piccolo point of care whole blood analyzer system and bringing the product to market
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT003013

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel